نتایج جستجو برای: paroxetine

تعداد نتایج: 1664  

Journal: :The American journal of psychiatry 2000
Z N Stowe L S Cohen A Hostetter J C Ritchie M J Owens C B Nemeroff

OBJECTIVE The purpose of this study was to determine the extent of infant medication exposure through breast-feeding during maternal treatment with paroxetine. METHOD Breast milk and paired maternal and infant sera were collected after 10 days of maternal treatment with paroxetine at a stable daily dose (10-50 mg/day). All samples were analyzed by means of high-performance liquid chromatograp...

Journal: :The New England journal of medicine 2006
Charles F Reynolds Mary Amanda Dew Bruce G Pollock Benoit H Mulsant Ellen Frank Mark D Miller Patricia R Houck Sati Mazumdar Meryl A Butters Jacqueline A Stack Mary Ann Schlernitzauer Ellen M Whyte Ariel Gildengers Jordan Karp Eric Lenze Katalin Szanto Salem Bensasi David J Kupfer

BACKGROUND Elderly patients with major depression, including those having a first episode, are at high risk for recurrence of depression, disability, and death. METHODS We tested the efficacy of maintenance paroxetine and monthly interpersonal psychotherapy in patients 70 years of age or older who had depression (55 percent of whom were having a first episode) in a 2-by-2, randomized, double-...

2018
Hyang Mi Lee Ok Hee Chai Sang June Hahn Bok Hee Choi

In patients with epilepsy, depression is a common comorbidity but difficult to be treated because many antidepressants cause pro-convulsive effects. Thus, it is important to identify the risk of seizures associated with antidepressants. To determine whether paroxetine, a very potent selective serotonin reuptake inhibitor (SSRI), interacts with ion channels that modulate neuronal excitability, w...

Journal: :Biological psychiatry 2000
M J Owens D L Knight C B Nemeroff

BACKGROUND The norepinephrine transporter (NET)/uptake site is an antidepressant-sensitive transporter located on plasma membranes of noradrenergic neurons and other specialized cells that remove norepinephrine (NE) from the synapse to terminate the actions of NE. The antidepressant paroxetine is believed to produce its therapeutic effects primarily by acting as a highly selective antagonist of...

Journal: :Radioisotopes 1990
K Hashimoto T Goromaru

The distribution of radioactivity in the mouse brain after intravenous administration of 3H-paroxetine was in the order (highest to lowest) hypothalamus greater than cerebral cortex greater than cerebellum. The radioactivity in the hypothalamus and cerebral cortex after injection of 3H-paroxetine was significantly decreased by treatment with 6-nitroquipazine or paroxetine. HPLC and TLC analyses...

Journal: :BMC Psychiatry 2004
Pinhas N Dannon Iulian Iancu Ami Cohen Katherine Lowengrub Leon Grunhaus Moshe Kotler

BACKGROUND This naturalistic open label follow-up study had three objectives: 1) To observe the course of illness in Panic Disorder patients receiving long-term versus intermediate-term paroxetine treatment, 2) To compare the relapse rates and side-effect profile after long-term paroxetine treatment between patients with Panic Disorder and Panic Disorder with Agoraphobia, 3) To observe paroxeti...

2017
Yuji Otsuka

There have been only two previous reports of paroxetine-induced corrected QT (QTc) prolongation on electrocardiogram (ECG). Here, we report a 43-year-old woman with QTc prolongation (476 ms). She had taken 50 mg of paroxetine for 17 days. Three days after discontinuation of paroxetine, QTc returned to within the normal limits (396 ms). Paroxetine blocks the human ether-a-go-go-related gene (HER...

Journal: :Pharmacological reports : PR 2012
Katarzyna Socała Dorota Nieoczym Elżbieta Wyska Ewa Poleszak Piotr Wlaź

BACKGROUND Sildenafil, a selective phosphodiesterase 5 (PDE5) inhibitor, has recently been reported to influence the antidepressant activity of some antidepressant drugs. The present study was undertaken to investigate the involvement of the nitric oxide/cyclic guanosine 3',5'-monophosphate/PDE5 (NO/cGMP/PDE5) signaling pathway in the antidepressant activity of paroxetine and to assess the inte...

Journal: :Neuropsychiatric Disease and Treatment 2007
Reiji Yoshimura Koshiro Tsuji Nobuhisa Ueda Jun Nakamura

We report two patients with psychotic depression who were successfully treated with a lithium addition to ongoing paroxetine treatment. In both cases, plasma brain-derived neurotrophic factor (BDNF) levels increased about 2-fold after lithium augmentation to paroxetine, compared with paroxetine treatment alone. Plasma paroxetine levels did not change after lithium addition. These results sugges...

Journal: :Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2011
A E Nardi A M Valença R C Freire M D Mochcovitch R Amrein A Sardinha M N Levitan I Nascimento V L de-Melo-Neto A L King A C de O E Silva A B Veras G P Dias G L Soares-Filho R T da Costa M A Mezzasalma M R de Carvalho A C de Cerqueira J E Hallak J A Crippa M Versiani

The objective of the present randomized, open-label, naturalistic 8-week study was to compare the efficacy and safety of treatment with clonazepam (N = 63) and paroxetine (N = 57) in patients with panic disorder with or without agoraphobia. Efficacy assessment included number of panic attacks and clinician ratings of the global severity of panic disorders with the clinical global impression (CG...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید